- NCT00022425
Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
Phase 1Unknown - NCT00022451
Tipifarnib in Treating Young Patients With Refractory Leukemia
Phase 1Completed - NCT00022464
CCI-779 in Treating Patients With Metastatic Melanoma
Phase 2Completed - NCT00022490
Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Phase 2Terminated - NCT00022516
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
Phase 3Completed - NCT00014222
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Phase 3Completed - NCT00022555
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
Phase 1Completed - NCT00022568
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1Unknown - NCT00045474
Brachytherapy in Treating Patients With Recurrent Malignant Glioma
Phase 1Completed - NCT00022581
Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 2Completed - NCT00022620
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
Phase 2Completed - NCT00022633
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Phase 2Terminated - NCT00033449
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 1Terminated - NCT00023634
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
Phase 1Terminated - NCT00022646
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 2Completed - NCT00022685
Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
Phase 3Unknown - NCT00022711
Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
Phase 2Completed - NCT00022724
CCI-779 in Treating Patients With Malignant Glioma
Phase 1Completed - NCT00002514
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
Phase 3Completed - NCT00004066
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Phase 2Completed - NCT00022022
Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Phase 3Unknown - NCT00049504
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Phase 2Completed - NCT00003636
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
Phase 3Completed - NCT00004028
Carmustine in Treating Patients With Recurrent Malignant Glioma
Phase 1Completed - NCT00024414
DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
Phase 2Unknown - NCT00004017
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
Phase 2Completed - NCT00003128
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Phase 3Completed - NCT00024375
DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
Phase 2Unknown - NCT00004011
S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase 3Completed - NCT00024297
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
Not ApplicableCompleted - NCT00024284
Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
Phase 1Completed - NCT00024258
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase 2Completed - NCT00024245
10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00004001
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 3Completed - NCT00024232
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Phase 2Completed - NCT00024180
FR901228 in Treating Patients With Hematologic Cancer
Phase 1Completed - NCT00003641
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Phase 3Active Not Recruiting - NCT00024167
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Phase 3Terminated - NCT00024115
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase 1Withdrawn - NCT00024089
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Phase 2Completed - NCT00006089
Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Phase 2Completed - NCT00030758
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
Phase 4Unknown - NCT00023985
Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase 1Completed - NCT00023972
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 3Completed - NCT00003981
E7070 in Treating Patients With Solid Tumors
Phase 1Completed - NCT00023946
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Phase 2Terminated - NCT00023751
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
Phase 2Completed - NCT00023894
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2Completed - NCT00002484
Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer
Phase 1Completed - NCT00026247
Radiofrequency Ablation in Treating Patients With Bone Metastases
Not ApplicableCompleted - NCT00019461
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2Completed - NCT00005979
Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
Phase 3Completed - NCT00027937
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
Phase 2Completed - NCT00022087
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Phase 3Completed - NCT00003204
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
Phase 3Completed - NCT00022113
EMD 121974 in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00007982
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer
Phase 2Completed - NCT00002757
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
Phase 3Completed - NCT00006469
Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer
Phase 2Completed - NCT00007995
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
Phase 2Completed - NCT00004077
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
Phase 2Completed - NCT00020358
Vaccine Therapy in Treating Patients With Melanoma
Phase 2Completed - NCT00004075
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Phase 1Completed - NCT00004072
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
Phase 2Completed - NCT00045500
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Phase 1Completed - NCT00002847
Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Phase 2Unknown - NCT00032149
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
Phase 1Unknown - NCT00047385
National Lung Screening Trial (NLST) Screening
Phase 3Completed - NCT00047346
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Phase 1Completed - NCT00047333
Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Phase 2Terminated - NCT00047307
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Phase 1Completed - NCT00047281
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Phase 2Completed - NCT00049309
Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer
Phase 2Completed - NCT00047255
Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Phase 3Completed - NCT00047242
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00025064
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
Phase 2Unknown - NCT00047229
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Phase 2Completed - NCT00047216
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
Phase 2Completed - NCT00047203
Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00047190
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Phase 2Completed - NCT00049010
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
Not ApplicableCompleted - NCT00047060
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Phase 1Completed - NCT00047047
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047034
E7389 in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047008
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Phase 3Completed - NCT00046943
Atrasentan in Treating Patients With Prostate Cancer
Phase 3Completed - NCT00046917
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00046904
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase 3Completed - NCT00046865
Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Phase 3Completed - NCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active Not Recruiting - NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Phase 2Completed - NCT00048971
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Completed - NCT00011960
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
Phase 2Completed - NCT00048984
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
Completed - NCT00049023
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Phase 1Completed - NCT00006468
Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3Unknown - NCT00002839
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
Phase 3Completed - NCT00049062
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Phase 2Completed - NCT00045734
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Phase 2Completed - NCT00049075
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2Completed